Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases

被引:25
作者
Hu, Jingping [1 ,2 ,3 ]
Ye, Mao [4 ,5 ,6 ]
Zhou, Zhiguang [1 ,2 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Endocrinol & Metab, Changsha 410011, Hunan, Peoples R China
[2] Cent South Univ, Key Lab Diabet Immunol, Minist Educ, Changsha 410011, Hunan, Peoples R China
[3] Natl Clin Res Ctr Metab Dis, Changsha 410011, Hunan, Peoples R China
[4] Hunan Univ, Coll Chem & Chem Engn, Mol Sci & Biomed Lab, Changsha 410082, Hunan, Peoples R China
[5] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China
[6] Hunan Univ, Collaborat Innovat Ctr Mol Engn Theranost, Coll Biol, Changsha 410082, Hunan, Peoples R China
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2017年 / 95卷 / 03期
基金
中国国家自然科学基金;
关键词
Diabetes mellitus; Aptamers; Oligonucleotides; INSULIN-RESISTANCE; DNA APTAMER; ELECTROCHEMICAL DETECTION; AUTOMATED SELECTION; MICROFLUIDIC ASSAYS; PEGAPTANIB SODIUM; ADIPOSE-TISSUE; SSDNA APTAMER; IN-VITRO; RNA;
D O I
10.1007/s00109-016-1485-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Diabetes mellitus is one of the most common chronic diseases that threatens human health in worldwide populations. Despite enormous efforts invested in the study of diabetes mellitus, the development of precise diagnoses and treatments for this disease remains difficult due to the limitations of current techniques. Therefore, new methods are currently being developed. Aptamers are oligonucleotides that bind to specific target molecules and have been widely applied as diagnostic and therapeutic tools. In recent years, aptamers have been utilized in the study of diabetes mellitus and metabolic diseases. In this review, we highlight recent developments and new perspectives on aptamers in the field of diabetes mellitus and other metabolic diseases. Aptamers could potentially provide the means for efficient diagnoses and therapies against diabetes mellitus.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 96 条
  • [71] Highly amplified detection of visceral adipose tissue-derived serpin (vaspin) using a cognate aptamer duo
    Raston, Nurul Hanun Ahmad
    Gu, Man Bock
    [J]. BIOSENSORS & BIOELECTRONICS, 2015, 70 : 261 - 267
  • [72] Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study
    Rinaldi, Michele
    Chiosi, Flavia
    dell'Omo, Roberto
    Romano, Mario R.
    Parmeggiani, Francesco
    Semeraro, Francesco
    Mastropasqua, Rodolfo
    Costagliola, Ciro
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (06) : 940 - 946
  • [73] Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers
    Rong, Yuan
    Chen, Hao
    Zhou, Xue-Feng
    Yin, Chang-Qing
    Wang, Bi-Cheng
    Peng, Chun-Wei
    Liu, Shao-Ping
    Wang, Fu-Bing
    [J]. ONCOTARGET, 2016, 7 (07) : 8282 - 8294
  • [74] RNA aptamers as reversible antagonists of coagulation factor IXa
    Rusconi, CP
    Scardino, E
    Layzer, J
    Pitoc, GA
    Ortel, TL
    Monroe, D
    Sullenger, BA
    [J]. NATURE, 2002, 419 (6902) : 90 - 94
  • [75] AN RNA MOTIF THAT BINDS ATP
    SASSANFAR, M
    SZOSTAK, JW
    [J]. NATURE, 1993, 364 (6437) : 550 - 553
  • [76] Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing
    Savory, Nasa
    Abe, Koichi
    Sode, Koji
    Ikebukuro, Kazunori
    [J]. BIOSENSORS & BIOELECTRONICS, 2010, 26 (04) : 1386 - 1391
  • [77] Development of DNA aptamers using Cell-SELEX
    Sefah, Kwame
    Shangguan, Dihua
    Xiong, Xiangling
    O'Donoghue, Meghan B.
    Tan, Weihong
    [J]. NATURE PROTOCOLS, 2010, 5 (06) : 1169 - 1185
  • [78] Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus
    Shah, P
    Vella, A
    Basu, A
    Basu, R
    Schwenk, WF
    Rizza, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) : 4053 - 4059
  • [79] Global estimates of the prevalence of diabetes for 2010 and 2030
    Shaw, J. E.
    Sicree, R. A.
    Zimmet, P. Z.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (01) : 4 - 14
  • [80] The pathogenesis of diabetic foot problems - An overview
    Shaw, JE
    Boulton, AJM
    [J]. DIABETES, 1997, 46 : S58 - S61